Hyderabad: Hyderabad-situated Medihauxe Pharma Pvt Ltd on Tuesday reported that it is completely equipped to store, handle and distribute COVID-19 vaccine in both Telangana and Andhra Pradesh as and when the vaccine is made accessible.
If creating the Vaccine accessible is one challenge, at that point distributing it to the public is another huge challenge. As indicated by Girish Bhat and P. Manohar, MD, and Director of Medihauxe Pharma, the size of adult vaccination circulation is immense to the point that such a size of distribution was not done previously.
Girish and Manohar, both said that they have insight and expertise in dealing with temperature-sensitive specialty medication and cold chain pharma items, their storage, and handling.
The organization stated, “Our facility is the state-of-the-art one and the warehouse infrastructure is one of the best in the country. We are equipped with the latest technology, coupled with time-tested systems, agile management to ensure world-class service.”
Girish Bhat said the 25-year-old firm that manages with critical care, life-saving super-specialty drug distribution, has the all-important infrastructure, for example, cold chain, walk in-cool rooms, and information loggers.
Medihauxe Pharma is the distributor of more than 3,000 super specialty items, the majority of which are life-saving and some are uncommon. It as of now manages medication categories, for example, cancer, liver, lung, kidney, and heart transplants. Its facilities are evaluated by worldwide pharma majors.
Right now, the turnover of the organization is Rs 180 crore, and has 120 workers. They said numerous private and government associations have been visiting Medihauxe Pharma for a study visit to comprehend its facilities.
The entire world is looking at pharma organizations for the vaccine while India is taking a look at Hyderabad, as four out of six vaccine creators in the nation are based here.
Girish Bhat includes, “As we are nearing to the vaccine, companies and the government machinery is looking at Medihauxe Pharma for its delivery in Telugu states as we have proven track record.”
The Polio vaccine focused on kids was done over many years. COVID-19 vaccine is a different sort of a ball game. Not at all like the Polio vaccine which can be directed by ASHA workers and others, the COVID-19 vaccine is an intramuscular infusion, and more experienced medical workers, for example, nurses are needed to administer it.
Girish accepts that individuals may probably require two dosages. The two doses of vaccine with a hole of one month in the middle of may add greater complexity to the distribution.
Another massive challenge will be the accessibility of clinical devices, for example, disposable needles, needles needed for the delivery of the vaccine. While demand is higher, the supply is not in similarity with the demand as organizations have been working with far fewer resources, stated Girish.
